Lee Ainslie's WST Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 722 shares of West Pharmaceutical Services, Inc. (WST) worth $267,689, representing 0.00% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 57,790 shares. Largest reduction occurred in Q2 2019, reducing 98,230 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +722 | New Buy | 722 | $370.76 |
| Q2 2024 | -994 | Sold Out | 0 | $0.00 |
| Q1 2024 | +994 | New Buy | 994 | $395.71 |
| Q4 2021 | -1,645 | Sold Out | 0 | $0.00 |
| Q3 2021 | +1,558 | Add 1790.80% | 1,645 | $424.32 |
| Q2 2021 | +87 | New Buy | 87 | $356.32 |
| Q2 2019 | -98,230 | Sold Out | 0 | $0.00 |
| Q1 2019 | -1,720 | Reduce 1.72% | 98,230 | $110.20 |
| Q4 2018 | +57,790 | Add 137.07% | 99,950 | $98.03 |
| Q3 2018 | +42,160 | New Buy | 42,160 | $123.46 |
Lee Ainslie's West Pharmaceutical Services Investment FAQs
Lee Ainslie first purchased West Pharmaceutical Services, Inc. (WST) in Q3 2018, acquiring 42,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held West Pharmaceutical Services, Inc. (WST) for 10 quarters since Q3 2018.
Lee Ainslie's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q4 2018, adding 99,950 shares worth $9.8 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 722 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $267,689.
As of the Q3 2026 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in West Pharmaceutical Services, Inc. (WST) was 99,950 shares, as reported at the end of Q4 2018.